Featured on the cover of Nature Machine Intelligence, one of Iambic Therapeutics‘ AI platforms, known as NeuralPLexer, can accurately predict protein-ligand complex structures. The platform excels at predicting the complex 3D structures formed when proteins bind with drug-like molecules. In a benchmark study featured in the publication, NeuralPLexer outperformed other systems, including AlphaFold2, in its…